Coastal Infusion Administers Ilumya™
| J-Code | J3245 |
|---|---|
| Manufacturer | Sun Pharma |
| First Approved | 03/21/2018 |
Coastal Infusion can administer your Ilumya prescription at any of our south Florida locations.
Ilumya (tildrakizumab) is used to treat plaque psoriasis, a disease causing red, scaly patches on the skin.
The active substance in Ilumya, tildrakizumab, is a monoclonal antibody (a type of protein) which is designed to attach to interleukin 23 and block its activity. Interleukin 23 is a substance that controls the growth and maturation of some types of T cells. These T cells, which are part of the immune system, causing inflammation that is linked to the development of plaque psoriasis. By blocking the action of interleukin 23, Ilumetri reduces inflammation and symptoms associated with the disease.
What It Treats
Ilumya is used to treat Plaque Psoriasis.
Prescribed By
Ilumya is most often prescribed by Dermatologists and Rheumatologists.
How it’s Administered
Ilumya is administered by subcutaneous injection. Ilumya injections take only a few minutes.
Frequency
Ilumya is generally administered every 12 weeks after two starter doses two four weeks apart.
Related Drugs
Omvoh, Skyrizi, Stelara, Tremfya
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies